The Humira patent thicket, the Noerr-Pennington doctrine and antitrust's patent problem

Nat Biotechnol. 2022 Dec;40(12):1761-1763. doi: 10.1038/s41587-022-01583-w.
No abstract available

MeSH terms

  • Adalimumab*

Substances

  • Adalimumab